ASHLEY STEMLEY: Open Payments
NPI 1942582739 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 63 payments from 12 companies in 2025. Trend: 2023 $790 · 2024 $2,528 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $558 |
| Amgen Inc. | 14 | $253 |
| ABBVIE INC. | 12 | $251 |
| Novartis Pharmaceuticals Corporation | 5 | $134 |
| Organon LLC | 6 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Arcutis Biotherapeutics, Inc. | 3 | $73 |
| LEO Pharma Inc. | 3 | $71 |
| UCB, Inc. | 2 | $70 |
| Galderma Laboratories, L.P. | 3 | $56 |
Products named: DUPIXENT, OTEZLA, RINVOQ, VTAMA, SKYRIZI, Rhapsido, Zoryve, ADBRY.
Industry payments across CA — which companies pay providers there.
